Bremer Trust National Association’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$450K Buy
8,811
+459
+5% +$23.2K 0.1% 173
2018
Q3
$485K Sell
8,352
-399
-5% -$19.5K 0.12% 159
2018
Q2
$424K Sell
8,751
-1,536
-15% -$71.7K 0.12% 177
2018
Q1
$478K Sell
10,287
-2,658
-21% -$115K 0.14% 146
2017
Q4
$487K Sell
12,945
-1,443
-10% -$53K 0.13% 150
2017
Q3
$525K Sell
14,388
-1,215
-8% -$46.3K 0.15% 141
2017
Q2
$615K Sell
15,603
-6,636
-30% -$242K 0.17% 123
2017
Q1
$697K Sell
22,239
-354
-2% -$11.1K 0.19% 120
2016
Q4
$706K Buy
22,593
+7,737
+52% +$251K 0.19% 127
2016
Q3
$597K Sell
14,856
-123
-0.8% -$4.63K 0.16% 138
2016
Q2
$498K Buy
14,979
+30
+0.2% +$1.03K 0.14% 146
2016
Q1
$440K Buy
14,949
+717
+5% +$19.8K 0.13% 148
2015
Q4
$374K Sell
14,232
-60
-0.4% -$1.56K 0.11% 155
2015
Q3
$339K Buy
+14,292
New +$345K 0.11% 165

Other funds holding EW

Bremer Trust National Association's EW Position: Q4 2018 in Review

Bremer Trust National Association increased its Edwards Lifesciences (EW) stake by 5.5% in Q4 2018, buying an estimated $23.2K and bringing the position to 8,811 shares worth $450K. The position accounts for 0.1% of the portfolio, ranked #173.

Bremer Trust National Association first reported a position in EW in Q3 2015 and has held it in 14 quarters since. The position peaked at $706K in Q4 2016. 875 funds tracked by Wall St. Rank hold EW as of Q4 2018.

  • Bremer Trust National Association held 8,811 shares of Edwards Lifesciences worth $450K as of Q4 2018.
  • Bremer Trust National Association bought 459 Edwards Lifesciences shares in Q4 2018, an estimated $23.2K.
  • Edwards Lifesciences made up 0.1% of Bremer Trust National Association's portfolio in Q4 2018, its #173 holding.
  • Bremer Trust National Association first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 14 quarters since.
  • Bremer Trust National Association's Edwards Lifesciences position peaked at $706K in Q4 2016.
  • 875 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.